Investor Relations

Print page     Email page

Myriad Pharmaceuticals, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing novel small molecule drugs that address severe medical conditions, including cancer and HIV infection. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.

Recent Releases Feb 16, 2010 Myriad Pharmaceuticals Reports Second Quarter FY' 2010 Financial Results Feb 3, 2010 Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th View all releases » Events & Presentations Apr 17, 2010 AACR 101st Annual Meeting Jun 4, 2010 ASCO Annual Meeting View all events & presentations »

Stock Chart 3 Mo.   6 Mo.   1 Yr. Stock Quote Myriad Pharmaceuticals, Inc. Price: 4.79 Change: 0.11 Day High: 4.79 Day Low: 4.66 Volume: 113,200 Delayed at least 20 minutes. Provided by eSignal.